论文信息 - Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study - 字舞流文

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study

E. Peeva | M. Dowty | A. Banerjee | J. Gale | M. Vincent | V. Pradhan | M. Scaramozza | E. Kieras | A. Fensome | Ravi Shankar P. Singh | E. Roberts | P. Winkle | C. Tehlirian | R. Singh